Cyclerion Therapeutics (NASDAQ: CYCN)

2d ago, source: The Motley Fool

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes ...

Cyclerion Therapeutics Inc Ordinary Shares CYCN

9d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023

14d ago, source: Hosted on MSN

Cyclerion Therapeutics (NASDAQ:CYCN) just reported results for the fourth quarter of 2023. Cyclerion Therapeutics reported earnings per share of -$1.60. The company did not report any revenue for ...

12 Best Biotech Penny Stocks to Invest In

26d ago, source: InvestingChannel on MSN

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) is a Boston-based biopharma firm founded in 2018. Cyclerion Therapeutics, Inc.

FHTX Foghorn Therapeutics Inc.

8h ago, source: Seeking Alpha

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin ...

Cyclerion Therapeutics Inc Ordinary Shares

26d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cyclerion Therapeutics, Inc. (CYCN)

25d ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...